Net Revenue: 150.0 M€ EBITDA: Request Information
The Investor is a pharmaceutical and biotechnology company, based in Europe, manufacturing more than 200 products and offer them to patients all around the world. The company is focused on multiple therapeutic areas, including cardiology, oncology, pulmonology, dermatology, gynaecology, urology, ophthalmology, angiology, psychiatry, allergology, gastroenterology, rheumatology, etc.
Listed by M&A World Support Center on Wednesday, 31 January 2018 [Investor (Buy-side)] - Ref.: 928
855 Hits